Similar articles

• Erythropoietin: from molecular biology to clinical use.

  Lacombe C. Lacombe C. Eur Cytokine Netw. 1997 Sep;8(3):308-10. Eur Cytokine Netw. 1997. PMID: 9346370 Review. No abstract available.
• Biology of erythropoietin.

  Jelkmann W. Jelkmann W. Clin Investig. 1994;72(6 Suppl):S3-10. Clin Investig. 1994. PMID: 7950169 Review.
• Erythropoietin 1997: a brief update.

  Gahl GM, Eckardt KU. Gahl GM, et al. Perit Dial Int. 1997;17 Suppl 2:S84-90. Perit Dial Int. 1997. PMID: 9163805 Review. No abstract available.
• Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?

  Lim VS. Lim VS. Semin Nephrol. 1990 Mar;10(2 Suppl 1):26-7. Semin Nephrol. 1990. PMID: 2356366 No abstract available.
• Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia.

  Ogino A, Takemura G, Kawasaki M, Tsujimoto A, Kanamori H, Li L, Goto K, Maruyama R, Kawamura I, Takeyama T, Kawaguchi T, Watanabe T, Moriguchi Y, Saito H, Fujiwara T, Fujiwara H, Minatoguchi S. Ogino A, et al. J Am Coll Cardiol. 2010 Nov 30;56(23):1949-58. doi: 10.1016/j.jacc.2010.04.068. J Am Coll Cardiol. 2010. PMID: 21109120